Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
1.76x
GUFICBIO's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.
Free Cash Flow
₹470.42M
GUFICBIO's free cash flow was ₹470.42M in FY 2025, up 139.2% from FY 2024.
Dividend Coverage
46.9x
GUFICBIO's free cash flow covered dividends 46.9x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
61.6%
Capital expenditure consumed 61.6% of operating cash flow in FY 2025 for GUFICBIO, typical of capital-intensive industries.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 861.36M | 696.49M | |
| Cash flow Operating Activities | -74.57M | 1.23B | |
| Investments in PPE | -1.13B | -755.26M | |
| Cash flow Investing Activities | -1.02B | -707.77M | |
| Dividend Paid | -9.72M | -10.03M | |
| Cash flow Financing Activities | 823.81M | -372.04M | |
| Cash at beginning of period | 286.02M | 11.37M | |
| Cash at end of period | 11.37M | 157.23M | |
| Free Cash Flow | -1.20B | 470.42M |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025